-
Eligibility for icosapent ethyl in a French population of coronary outpatients with type 2 diabetes.
- Pierre François Sabouret, Jean-Claude Dib, Fiona Ecarnot, Maciej Banach, and Nicolas Lellouche.
- Sorbonne University, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière Hospital (AP-HP), France.
- Arch Med Sci. 2023 Jan 1; 19 (6): 190119031901-1903.
IntroductionWe determined eligibility for icosapent ethyl (EPA) treatment in coronary artery disease (CAD).MethodsConsecutive patients with type 2 diabetes and CAD were prospectively included from 03/2019 to 12/2020.Results574 patients were included; mean age 71 years, 81% males, with a high prevalence of other risk factors (81% hypertension). Mean lipid-density lipoprotein cholesterol was 85 mg/dl, mean glycated hemoglobin HbA1c 7.1%, mean triglycerides 148 mg/dl; 82% received statins. Based on National Lipid Association criteria, 31% would be eligible for EPA.ConclusionsIn this contemporary survey in consecutive, unselected CAD patients in daily practice, almost a third would be potentially eligible for EPA.Copyright: © 2023 Termedia & Banach.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..